Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

Annals of Internal Medicine

Volumn 107, Issue 4, 1987, Pages 451-458

  Evans, W K ^a   Feld, R ^a   Murray, N ^a   Willan, A ^a   Coy, P ^a   Osoba, D ^a   Shepherd, F A ^a   Clark, D A ^a   Levitt, M ^a   MacDonald, A ^a   Wilson, K ^a   Shelley, W ^a   Pater, J ^a  

^a Queen's Cancer Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; DRUG COMPARISON; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; RESPIRATORY SYSTEM; SMALL CELL CARCINOMA; THERAPY;

EID: 0023626670     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-107-4-451     Document Type: Article

References (0)